Prescription Drug User Fee Act reauthorization.
FY 2013 funding regarding the FDA. Economic policy. Prescription Drug User Fee Act reauthorization.
Biosimilar products. Medicare Part B reimbursement and coverage of dialysis products.
BUD - Budget/Appropriations ECN - Economics/Economic Development HCR - Health Issues MMM - Medicare/Medicaid
11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS) 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 13 - Office of the Vice President of the United States 1 - SENATE 39 - State, Dept of (DOS)
PODESTA GROUP, INC.
1001 G Street, NW, Suite 1000 West, Washington, DC, 20001, US
ANTHONY PODESTA SHARON COHEN ANTHONY PODESTA ANTHONY PODESTA SHARON COHEN ANTHONY PODESTA SHARON COHEN OSCAR RAMIREZ